entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
101927750,ATP6V1B1-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,6.26836835586331,0.551181839192465,0.780797818392689,0.705921336111184,0.480237058249363,0.961473650102656,NA
101927750,ATP6V1B1-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,7.09091377418972,-0.245335810387898,0.705472264137584,-0.347761099705051,0.728019606198157,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
101927750,ATP6V1B1-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,6.12969905992275,-0.0350202416503174,0.893996238770846,-0.0391726946172242,0.96875270346028,0.99673522052731,A549
101927750,ATP6V1B1-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,6.57822693467376,0.847661192817397,0.7773706964643,1.09042082068799,0.275527814419308,0.986418245486816,A549
101927750,ATP6V1B1-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,4.30512456775001,-5.36977685393732,2.00024312925233,-2.68456207918309,0.0072624894632666,0.0243432092108406,A549
101927750,ATP6V1B1-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,0.554857118202679,-1.80404398631218,3.24694587466287,-0.555612583625063,0.57847572721065,1,sigmoid colon organoid
101927750,ATP6V1B1-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,0.554857118202679,0.606369046579816,3.13739476306757,0.19327151741241,0.846746331574086,1,sigmoid colon organoid
